The Biden administration promoted the use of puberty blockers for transgender children by citing a study from an LGBT group funded in part by a manufacturer of the controversial drugs used in gender reassignment.
In statements commemorating "Transgender Day of Visibility," the White House and Department of Health and Human Services cited research from the Trevor Project to support the use of puberty blockers, hormone therapy, and sex-reassignment procedures in children seeking to change genders.
The Biden administration's support for "Gender-affirming" care, the progressive buzzword for gender transitions, comes as conservatives push to stop the prescription of hormones and puberty blockers to children.
Texas attorney general Ken Paxton subpoenaed AbbVie and drug maker Endo Pharmaceuticals, claiming both companies improperly promote the use of puberty blockers in transgender children.
Though the medical gender transition industry is growing rapidly, some researchers say puberty blockers and hormone treatments for children have not been studied enough to ensure their safety.
The Biden administration's endorsement could pave the way for broader acceptance of the use of puberty blockers and hormone therapy in children.
The White House said in its fact sheet on Transgender Day of Visibility that children who identify as transgender have "The right to access gender-affirming health care."
https://freebeacon.com/biden-administration/white-house-pushes-puberty-blockers-for-trans-kids/
No comments:
Post a Comment